Scilex Holding Co·4

Jan 17, 8:27 PM ET

SCLX Stock Acquisition JV LLC 4

4 · Scilex Holding Co · Filed Jan 17, 2025

Insider Transaction Report

Form 4
Period: 2025-01-16
Transactions
  • Other

    Common Stock

    2025-01-16779,37154,289,214 total
Footnotes (1)
  • [F1]Transferred in connection with a First Amendment to License and Commercialization Agreement (the "License Amendment") the Issuer entered into with Rxomeg Therapeutics, LLC a/k/a Romeg Therapeutics, LLC ("Romeg"), as contemplated by that certain Transfer Agreement entered into between the Issuer and Romeg (the "Transfer Agreement"). In consideration of the execution of the License Amendment and the Transfer Agreement, the Reporting Person transferred to Romeg an aggregate of 779,371 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4